Results for “Protection Challenges” — Page 75

DOE OSTI2016

MO-D-BRC-00: In Memoriam of Jan Van De Geijn: Knowledge-Based Planning

Treatment planning is a central part of radiation therapy, including delineation in tumor volumes and critical organs, setting treatment goals of prescription doses to the tumor targets and tolerance doses to the critical organs, and finally generation of treatment plans to meet the treatment goals. National groups like RTOG have led the effort to standardize treatment goals of the prescription doses to the tumor targets and tolerance doses to the critical organs based on accumulated knowledge from decades of abundant clinical trial experience. The challenge for each clinical department is how to achieve or surpass these set goals within the time constraints of clinical practice. Using fifteen testing cases from different treatment sites such as head and neck, prostate with and without pelvic lymph nodes, SBRT spine, we will present clinically utility of advanced planning tools, including knowledge based, automatic based, and multiple criteria based tools that are clinically implemented. The objectives of this session are: Understand differences among these three advanced planning tools Provide clinical assessments on the utility of the advanced planning tools Discuss clinical challenges of treatment planning with large variations in tumor volumes and their relationships with adjacent critical organs. Ping Xia received research grant from Philips. Jackie Wu received research grant from Varian; P. Xia, Research support by Philips and Varian; Q. Wu, NIH, Varian Medical.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

TH-D-BRC-01: Panel Member

Interest in proton therapy has increased dramatically in the past couple of years, especially in the United States. There certainly is an important place for proton therapy in the arsenal of cancer treatments. Its dosimetric advantage and potential for low toxicity makes it the perfect partner for photons and other cancer treatment modalities. Often there is a belief that the new technology ought to be better but many believe that they should be widely adopted in the clinic only after evidence has shown that they are at least as safe and efficacious as existing technologies, which are often less expensive. This is the case for proton radiotherapy. This session being both educational and debate will provide a good review of basics and technological advancement as well as a comprehensive clinical update for both proton and photon therapy. Future technology developments and how they will impact the potential dosimetric advantage of proton therapy will be discussed. Particularly the debate will focus on whether these developments will close or widen the gap between photon and proton therapy. Learning Objectives: To review challenges, limitations, and recent and future developments in proton therapy. To review challenges, limitations, recent and future developments in photon radiotherapy. To review current clinical trials and challenging clinical cases. C. Yu, No company or organization that my presentation mentions provided me with financial support. I am the Founder and CEO of Xcision Medical Systems, LLC. However, my presentation will not mention any product or technology developed by Xcision.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

TH-D-BRC-02: Panel Member

Interest in proton therapy has increased dramatically in the past couple of years, especially in the United States. There certainly is an important place for proton therapy in the arsenal of cancer treatments. Its dosimetric advantage and potential for low toxicity makes it the perfect partner for photons and other cancer treatment modalities. Often there is a belief that the new technology ought to be better but many believe that they should be widely adopted in the clinic only after evidence has shown that they are at least as safe and efficacious as existing technologies, which are often less expensive. This is the case for proton radiotherapy. This session being both educational and debate will provide a good review of basics and technological advancement as well as a comprehensive clinical update for both proton and photon therapy. Future technology developments and how they will impact the potential dosimetric advantage of proton therapy will be discussed. Particularly the debate will focus on whether these developments will close or widen the gap between photon and proton therapy. Learning Objectives: To review challenges, limitations, and recent and future developments in proton therapy. To review challenges, limitations, recent and future developments in photon radiotherapy. To review current clinical trials and challenging clinical cases. C. Yu, No company or organization that my presentation mentions provided me with financial support. I am the Founder and CEO of Xcision Medical Systems, LLC. However, my presentation will not mention any product or technology developed by Xcision.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

TH-D-BRC-03: Panel Member

Interest in proton therapy has increased dramatically in the past couple of years, especially in the United States. There certainly is an important place for proton therapy in the arsenal of cancer treatments. Its dosimetric advantage and potential for low toxicity makes it the perfect partner for photons and other cancer treatment modalities. Often there is a belief that the new technology ought to be better but many believe that they should be widely adopted in the clinic only after evidence has shown that they are at least as safe and efficacious as existing technologies, which are often less expensive. This is the case for proton radiotherapy. This session being both educational and debate will provide a good review of basics and technological advancement as well as a comprehensive clinical update for both proton and photon therapy. Future technology developments and how they will impact the potential dosimetric advantage of proton therapy will be discussed. Particularly the debate will focus on whether these developments will close or widen the gap between photon and proton therapy. Learning Objectives: To review challenges, limitations, and recent and future developments in proton therapy. To review challenges, limitations, recent and future developments in photon radiotherapy. To review current clinical trials and challenging clinical cases. C. Yu, No company or organization that my presentation mentions provided me with financial support. I am the Founder and CEO of Xcision Medical Systems, LLC. However, my presentation will not mention any product or technology developed by Xcision.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

TH-D-BRC-04: Panel Member

Interest in proton therapy has increased dramatically in the past couple of years, especially in the United States. There certainly is an important place for proton therapy in the arsenal of cancer treatments. Its dosimetric advantage and potential for low toxicity makes it the perfect partner for photons and other cancer treatment modalities. Often there is a belief that the new technology ought to be better but many believe that they should be widely adopted in the clinic only after evidence has shown that they are at least as safe and efficacious as existing technologies, which are often less expensive. This is the case for proton radiotherapy. This session being both educational and debate will provide a good review of basics and technological advancement as well as a comprehensive clinical update for both proton and photon therapy. Future technology developments and how they will impact the potential dosimetric advantage of proton therapy will be discussed. Particularly the debate will focus on whether these developments will close or widen the gap between photon and proton therapy. Learning Objectives: To review challenges, limitations, and recent and future developments in proton therapy. To review challenges, limitations, recent and future developments in photon radiotherapy. To review current clinical trials and challenging clinical cases. C. Yu, No company or organization that my presentation mentions provided me with financial support. I am the Founder and CEO of Xcision Medical Systems, LLC. However, my presentation will not mention any product or technology developed by Xcision.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2024

Digital risk analysis in nuclear engineering projects: Designing for safety, performance, reliability, and security

Cyber-informed engineering and security-by-design frameworks are important in promoting the need to identify cybersecurity concerns early in the systems engineering lifecycle so risks from adversarial cyber-attacks can be eliminated or reduced through engineering design practices. In addition to adversarial risk, risk in operational technology systems also includes non-adversarial and unintentional risk from other factors such as human performance errors, environmental conditions, design flaws, and device degradation or failure. This paper introduces a new concept for characterizing digital risk, both adversarial and non-adversarial, and provides the basis for initial research into a novel digital risk analysis approach focused on incorporating attack difficulty into a multi-attribute analysis technique using robust decision-making. This digital risk characterization is also used to frame a discussion on the challenges of competing objectives and competing stakeholder requirements in an integrated energy system project that incorporates a small modular reactor and industrial facility.

22 GENERAL STUDIES OF NUCLEAR REACTORS↗

DOE OSTI2024

Innovative Advanced Hydrogen Mobile Fueler (Final Technical Report)

The US Department of Energy (DOE) funded a project to design, develop, deploy and analyze the economic viability of an innovative Advanced Hydrogen Mobile Fueler (AHMF). As part of the design activity the project team defined specifications based upon vehicle requirements and compliance with specific fueling performance criteria. The AHMF was originally designed to fuel 10-20 fuel cell vehicles (FCV) per day, consistent with the requirements of the H70 fueling category. The AHMF is able to operate without remote power connections, is modular for easy transport and deployment, and can provide expanded daily capacity and multi-day operations using delivered gaseous hydrogen. Toward the end of the project, due to request from the hydrogen industry and some necessary modifications of the AHMF, the system is now modified to fuel heavy duty vehicles. The project was conducted over two primary phases, each including several key tasks, subtasks, and project milestones. Phase 1 involved the design, development, and construction of the AHMF, moving from a conceptual design through to completion of assembly and testing. In addition to reviewing several different approaches, the team chose to take a conventional station design and modify it for mobile fueling. There were several innovative components included in the design. The high pressure storage was the first to achieve a US Department of Energy (DOE) Special Permit (SP 20391) to transport high pressure hydrogen (95 MPa) in a composite cylinder. The second novel system was a liquid nitrogen (LIN) cooling system with a compact heat exchanger. Without this change, the cooling system would not be able to fit into the AHMF. Phase 2 demonstrated the AHMF by fueling fuel cell buses at a fleet in Pomona, CA. The site was chosen because a temporary fueling solution was required while a fixed station was being installed. The existing permits for the fixed station and non-public access also was a determining factor. Over two months, the buses were fueled 320 times with over 5000 kg of hydrogen from tube trailers. Existing shore power was used, and the average electrical efficiency was 0.13 kWh/kg. The average liquid nitrogen (LIN) consumption was 90.68 scf/kg. The fueling and consumption data was provided to the National Renewable Energy Laboratory (NREL) for analysis. An economic analysis was performed and will be provided in a separate report. The project was successful, but not without challenges and lessons learned. The DOT special permit led the way for the use of high pressure, composite cylinders and is being by multiple other systems and applications. The pandemic along with time for the DOT special permit approval delayed the project for years. The team also believes that hydrogen mobile fueling has a use for the industry, especially during this upcoming phase of expansion. However, it does have its limitations due to high cost to build and operate, and the same permitting challenges as a fixed station. A fully capable system at the speeds and pressures of the AHMF may not be necessary for most applications and would help reduce the cost and increase storage capacity. The on-board generator can be easily replaced with shore power or the wide range of power generation solutions in the marketplace. One of the major results of the project was the development of new code language in National Fire Protection Agency (NFPA) 2 and the International Fire Code (IFC) for on-demand mobile fueling. This will provide guidance for Authorities Having Jurisdiction (AHJ) and user on how to permit temporary fueling sites across the nation.

08 HYDROGEN↗

DOE OSTI2026

Quantification of [MTBD][beti] loading and its effects on Pt/HSC electrode performance in hydrogen fuel cells

High surface area carbon-supported platinum catalysts (Pt/HSC) are widely used in polymer electrolyte membrane fuel cells but often suffer from limited proton and oxygen transport within porous domains. To address these challenges, we integrate the ionic liquid [MTBD][beti] into Pt/HSC catalyst layers using two deposition methods-one-pot and sequential deposition-to tune IL distribution within micropores and mesopores. A combination of ex situ and in operando techniques were employed to elucidate electrode structure-performance relationships across a range of IL loadings. Sequential deposition achieved more efficient pore filling and higher IL retention at lower IL:C ratios, enabling enhanced proton conductivity and protection of active sites. Compared to the IL-free Pt/HSC, IL-modified electrodes demonstrated up to 28% improvement in mass activity and enhanced high-current-density performance under low relative humidity, while maintaining comparable performance under humidified conditions. Electrochemical impedance spectroscopy and CO displacement experiments reveal that improvements are linked to reduced ionic resistance and lower sulfonate adsorption on Pt sites, rather than changes in electrochemical surface area. However, excessive IL loading leads to mass transport losses. These results highlight the importance of selective pore filling and efficient IL distribution in achieving kinetic gains without compromising ionic and gas transport.

08 HYDROGEN↗

DOE OSTI2014

Multifunctional ultra-high vacuum apparatus for studies of the interactions of chemical warfare agents on complex surfaces

A fundamental understanding of the surface chemistry of chemical warfare agents is needed to fully predict the interaction of these toxic molecules with militarily relevant materials, catalysts, and environmental surfaces. For example, rules for predicting the surface chemistry of agents can be applied to the creation of next generation decontaminants, reactive coatings, and protective materials for the warfighter. Here, we describe a multifunctional ultra-high vacuum instrument for conducting comprehensive studies of the adsorption, desorption, and surface chemistry of chemical warfare agents on model and militarily relevant surfaces. The system applies reflection-absorption infrared spectroscopy, x-ray photoelectron spectroscopy, and mass spectrometry to study adsorption and surface reactions of chemical warfare agents. Several novel components have been developed to address the unique safety and sample exposure challenges that accompany the research of these toxic, often very low vapor pressure, compounds. While results of vacuum-based surface science techniques may not necessarily translate directly to environmental processes, learning about the fundamental chemistry will begin to inform scientists about the critical aspects that impact real-world applications.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

DOE OSTI2025

Development of a reliable Potting process for Photoconductive Semiconductor Switches (PCSS)

Electrical potting is an important process to protect semiconductor devices from damaging external elements (mechanical stress, moisture, high voltage, etc.) and provides structural support for delicate devices for electrical connectivity to a larger platform. This internship will focus on the development of a universal potting jig for photoconductive semiconductor switches (PCSS). The goal is to design a reliable compression jig that is cross compatible with various PCSS designs that allow for easy potting of devices with a high dielectric breakdown strength material. The challenge with the current potting jig is that the design is only compatible with one style of PCSS and applies uneven pressure that can lead to leakage of potting material. Our approach is to move from a design that applies pressure by binder clip to utilizing a micrometer based compressing jig for a reliable packaging process that can pot a variety of devices without having to have a unique compressing jig for each of style of PCSS. Possible roadblocks with the new design include epoxy leakage into the optical path and misalignment of the electrode – metal contact bond.

42 ENGINEERING↗

DOE OSTI2015

Installation and operation of GeoMelt{sup R} in container vitrification in NNL Central Lab active rig hall at Sellafield - 15328

Cleanup and subsequent immobilization of wastes on the UK's NDA estate brings major challenges. With the exception of HLW where vitrification is utilized for immobilization, cement is typically used in the management and immobilization of non-heat generating wastes. However some legacy feeds such as those containing reactive metals can be incompatible with cementation technologies, and the application of engineered cement encapsulating product to raw wastes increases wasteform volume. Cementation has also been developed to be compatible with the repository concept, which provides it with a level of protection from the environment. Potential delays in repository implementation and as yet to be determined repository waste form acceptance criteria for some wastes may require the duration of above ground storage of immobilized wastes to be extended with potential effect on the integrity of the wasteform. Vitrification is a treatment option which destroys organics and hazardous inorganics such as asbestos, reduces wasteform volume, and produces a robust leach resistant wasteform. Kurion's GeoMelt{sup R} In-container Vitrification (ICV){sup TM} is a vitrification process wherein the treatment vessel can serve as an interim-storage, transport, and final long-term storage vessel - thus negating the need to pour glass into a separate container, effectively leading to a much simpler system than traditional waste melters. The inherent volume reduction from vitrification results in a dense product with self-shielding properties, and the GeoMelt treatment process has been demonstrated to homogenize elemental metals and radionuclide contaminants of concern, eliminating hot spots and mitigating criticality concerns. All of which opens up alternatives strategies for storage and disposal. GeoMelt has been proven in the commercial and US DOE waste treatment environment with over 26,000 tonnes of hazardous waste treated to date (half of this radioactive). Kurion and the UK's National Nuclear Laboratory (NNL) plan to demonstrate its application to Sellafield radioactive wastes. A small (engineering) scale demonstrator is being installed in the active rig hall at NNL's Central Laboratory at Sellafield UK with a twofold mission; 1) demonstration of the vitrification of ILW/LLW, and 2) processing of smaller volume orphan wastes that currently have no treatment path. The NNL facility will allow the handling of uranium containing materials which form a substantial component of ILW currently stored on the Sellafield site. Accurate DFs across the melter and off gas system are often difficult to obtain using inactive materials at the low concentrations present in radioactive wastes. Installation in the NNL facility will allow trace quantities of active species such as Cs-137 and Tc-99 to be processed as part of a simulant ILW stream and monitoring will allow accurate decontamination factors (DFs) to be established to support future vitrification facility design. In addition to underpinning melter operation and obtaining DFs across the system, the facility will allow the processing of radioactive waste arisings of low activity which may either be typical of larger waste volumes or may present as orphans without a disposition route. In either case the melter facility will be able to vitrify these wastes into a form that will be suitable for interim storage and disposal. Among the feeds envisaged for processing will be asbestos from power stations, contaminated soils, feeds containing uranium metals, ponds solids, sludge, and miscellaneous active laboratory wastes. The NNL Central Lab capability will be used to analyze the active product to support disposal requirements whether through letters of compliance for the Geological Disposal Facility (GDF) or waste acceptance criteria for the Low Level Waste Repository (LLWR). (authors)

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

DOE OSTI2018

Contact Challenge of Cattle with Foot-and-Mouth Disease Virus Validates the Role of the Nasopharyngeal Epithelium as the Site of Primary and Persistent Infection

The pathogenesis of foot-and-mouth disease virus (FMDV) in cattle was investigated through early and late stages of infection by use of an optimized experimental model for controlled contact exposure. Time-limited exposure of cattle to FMDV-infected pigs led to primary FMDV infection of the nasopharyngeal mucosa in both vaccinated and nonvaccinated cattle. In nonvaccinated cattle, the infection generalized rapidly to cause clinical disease, without apparent virus amplification in the lungs prior to establishment of viremia. Vaccinated cattle were protected against clinical disease and viremia; however, all vaccinated cattle were subclinically infected, and persistent infection occurred at similarly high prevalences in both animal cohorts. Infection dynamics in cattle were consistent and synchronous and comparable to those of simulated natural and needle inoculation systems. However, the current experimental model utilizes a natural route of virus exposure and is therefore superior for investigations of disease pathogenesis and host response. Deep sequencing of viruses obtained during early infection of pigs and cattle indicated that virus populations sampled from sites of primary infection were markedly more diverse than viruses from vesicular lesions of cattle, suggesting the occurrence of substantial bottlenecks associated with vesicle formation. These data expand previous knowledge of FMDV pathogenesis in cattle and provide novel insights for validation of inoculation models of bovine FMD studies. IMPORTANCE: Foot-and-mouth disease virus (FMDV) is an important livestock pathogen that is often described as the greatest constraint to global trade in animal products. The present study utilized a standardized pig-to-cow contact exposure model to demonstrate that FMDV infection of cattle initiates in the nasopharyngeal mucosa following natural virus exposure. Furthermore, this work confirmed the role of the bovine nasopharyngeal mucosa as the site of persistent FMDV infection in vaccinated and nonvaccinated cattle. The critical output of this study validates previous studies that have used simulated natural inoculation models to characterize FMDV pathogenesis in cattle and emphasizes the importance of continued research of the unique virus-host interactions that occur within the bovine nasopharynx. Specifically, vaccines and biotherapeutic countermeasures designed to prevent nasopharyngeal infection of vaccinated animals could contribute to substantially improved control of FMDV.

cattle↗

DOE OSTI2019

Laboratory Directed Research and Development (LDRD) 2018 Annual Report

Sandia executes its broad national security missions through five major mission portfolios: Advanced Science & Technology, Nuclear Deterrence, Global Security, National Security Programs, and Energy & Homeland Security. The LDRD program is key to developing capabilities to address our national security mission challenges. LDRD Mission Foundations, aligned to the Program Portfolios, conduct applied research in areas directly relevant to current/anticipated missions to develop and demonstrate new capabilities and prototype new solutions.

36 MATERIALS SCIENCE↗

DOE OSTI2018

Bradwell - The first UK Nuclear Site to Enter Care and Maintenance - 18152

Magnox Ltd, a Cavendish Fluor company, is currently decommissioning twelve nuclear sites on behalf of the UK Nuclear Decommissioning Authority (NDA). Ten of these sites are former Power Stations; the other two are closed Research and Development facilities. An overall strategy for decommissioning the Magnox sites has been agreed between Magnox and the NDA. For all but one of these sites the decommissioning strategy involves an extended quiescent period, known as Care and Maintenance (C and M), during which remaining radiological hazards reduce naturally through radioactive decay. After this quiescent period the sites will be restored to an agreed end state through further decommissioning and clearance work. Sites in C and M will not be permanently manned. They will be passively safe such that prompt action will not be required in response to an alarm or fault. Preparing a nuclear site for C and M involves several inter-related strands of work including definition of the intended physical configuration of the site during C and M (the C and M entry state), establishing a safety case to support that configuration, carrying out the physical works needed to deliver the C and M entry state, preparing arrangements and a team to manage the site during C and M and consolidating the knowledge and information needed to support C and M and final clearance of the site. To enter C and M there needs to be a carefully controlled transition of site, personnel and management system into the agreed C and M configuration. Bradwell, a site on the east coast of England, was selected as part of the overall decommissioning strategy for 'early' entry into C and M; Bradwell is scheduled to enter C and M in late 2018, several years in advance of the next scheduled site, with the intent of carrying learning forward from Bradwell to the subsequent sites. Bradwell is now in the final stages of preparation for C and M. Decommissioning commenced on completion of defueling in 2005. A clearly defined C and M entry state was established early in decommissioning and, through interaction with Regulators and internal and external stakeholders, developed as a shared target, thus providing certainty to the scope of the overall decommissioning project. The site has subsequently been systematically decommissioned to meet this target C and M entry state. All legacy waste has been retrieved and packaged into robust disposal containers, the reactor buildings have a new weather envelope, and much of the site is empty space with concrete hardstanding where facilities used to exist and bare rooms where plant used to operate. The remaining radiological and environmental hazards are not significant. During C and M, which is anticipated to last for 70 years, Bradwell will be managed remotely without the requirement for personnel to be present on site, with the possible exception of an ongoing security presence when the site first enters C and M. In terms of UK decommissioning, many of the projects undertaken at Bradwell were first of a kind. The company operates under a programmed organisational and delivery model, which will enable innovation and learning from Bradwell to be carried forward across the whole Magnox fleet. In addition to decommissioning tools and techniques, processes to manage decommissioning, optimise the C and M entry state to reduce the burden on the UK taxpayer and to transition a site into C and M have been developed. This, in addition to taking people from Bradwell and seeding them into Magnox and the broader UK nuclear industry, should help to provide long term cost savings and delivery efficiencies across the entire NDA estate. This paper describes the journey of Bradwell Site through decommissioning and into C and M, highlighting the innovation and challenges that have contributed to the success of delivering the first UK nuclear site into Care and Maintenance. (authors)

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

DOE OSTI2021

Self-Stabilized LiNi 0.8 Mn 0.1 Co 0.1 O 2 in thiophosphate-based all-solid-state batteries through extra LiOH

Nickle-rich LiNi 0.8 Co 0.1 Mn 0.1 O 2 (NMC 811) cathode material exhibits engaging properties in high energy density and low cost, making it great potential for the next generation high-energy all-solid-state lithium batteries (ASSLBs). However, NMC 811 suffers from severe surface electrochemical, chemical, and voltage incompatibility towards solid-state electrolytes (SSE), especially thiophosphate-based electrolytes like Li 6 PS 5 Cl. Although diverse coating methods have been made to overcome this issue, they are typically cumbersome and expensive. A coating strategy that satisfied all the requirements of cost-efficiency, stability, uniformity, scalability, and easy-achieving is still challenging. Here, we developed a LiOH-based surface stabilization strategy that provides a ~10 nm stable permeable layer on NMC 811. After one-step sintering of NMC 811 precursor mixed with LiOH, which is commonly used for NMC 811 lithiation process, excessive LiOH simultaneously distributes on NMC 811 particles. Unlike other reported methods, this coating method can be easily controlled and fabricated without additional complicated processes. By simply controlling the thickness of LiOH layer, which protects the Li 6 PS 5 Cl solid electrolyte materials from being oxidized, optimized cycling stability can be obtained for 600 cycles with capacity of 130 mAh g – 1 on average at a wide electrochemical window of 2.50–4.20 V (vs. Li-In).

25 ENERGY STORAGE↗

DOE OSTI2024

Computationally restoring the potency of a clinical antibody against Omicron

The COVID-19 pandemic underscored the promise of monoclonal antibody-based prophylactic and therapeutic drugs and revealed how quickly viral escape can curtail effective options. When the SARS-CoV-2 Omicron variant emerged in 2021, many antibody drug products lost potency, including Evusheld and its constituent, cilgavimab. Cilgavimab, like its progenitor COV2-2130, is a class 3 antibody that is compatible with other antibodies in combination4 and is challenging to replace with existing approaches. Rapidly modifying such high-value antibodies to restore efficacy against emerging variants is a compelling mitigation strategy. We sought to redesign and renew the efficacy of COV2-2130 against Omicron BA.1 and BA.1.1 strains while maintaining efficacy against the dominant Delta variant. Here we show that our computationally redesigned antibody, 2130-1-0114-112, achieves this objective, simultaneously increases neutralization potency against Delta and subsequent variants of concern, and provides protection in vivo against the strains tested: WA1/2020, BA.1.1 and BA.5. Deep mutational scanning of tens of thousands of pseudovirus variants reveals that 2130-1-0114-112 improves broad potency without increasing escape liabilities. Our results suggest that computational approaches can optimize an antibody to target multiple escape variants, while simultaneously enriching potency. Our computational approach does not require experimental iterations or pre-existing binding data, thus enabling rapid response strategies to address escape variants or lessen escape vulnerabilities.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2014

Construction challenges and solutions in TAMU3, a 14 T stress-managed Nb{sub 3}Sn dipole

The Accelerator Research Laboratory at Texas A and M University is nearing completion of a Nb{sub 3}Sn dipole that incorporates stress management directly in its windings. The windings utilize graded-cross-section cable made from 54/61 (54 out of a 61 subelement hexagonal pattern) Restacked Rod Processed® Nb{sub 3}Sn/Cu conductor and fine-filament S-2 glass fabric insulation. Coil heat treatment and associated differential expansions have brought about some tin leakage, highresistance electrical shorts, and coil gaps. TAMU3b impregnation successfully increased the coil-to-ground resistance. Quench protection in TAMU3 was simulated using QUENCH. The tests of TAMU3 should provide the first examination of stress management at field intensities greater than 12 T.

43 PARTICLE ACCELERATORS↗

DOE OSTI2026

Optimal Client Sampling in Federated Learning with Client-level Heterogeneous Differential Privacy

Federated Learning with client-level differential privacy (DP) provides a promising framework for collaboratively training models while rigorously protecting clients’ privacy. However, classic approaches like DP-FedAvg struggle when clients have heterogeneous privacy requirements, as they must uniformly enforce the strictest privacy level across all clients, leading to excessive DP noise and significant degradation in model utility. Existing methods to improve the model utility in such heterogeneous privacy settings often assume a trusted server and are largely heuristic, resulting in suboptimal performance and lacking strong theoretical foundations. Here, in this work, we address these challenges under a practical attack model where both clients and the server are honest-but-curious. We propose GDPFed, which partitions clients into groups based on their privacy budgets and achieves client-level DP within each group to reduce the privacy budget waste and hence improve the model utility. Based on the privacy and convergence analysis of GDPFed, we find that the magnitude of DP noise depends on both model dimensionality and the per-group client sampling ratios. To further improve the performance of GDPFed, we introduce GDPFed+, which integrates model sparsification to eliminate unnecessary noise and optimizes per-group client sampling ratios to minimize convergence error. Extensive empirical evaluations on multiple benchmark datasets demonstrate the effectiveness of GDPFed+, showing substantial performance gains compared with state-of-the-art methods.

Xu, Jiahao [Univ. of Nevada, Reno, NV (United Stat↗